BKYI customers relationship map

BIO-key (BKYI) customer relationships: who buys its IAM and how it monetizes

BIO-key International sells biometric and identity‑access management (IAM) software and hardware under a partner‑centric model that is predominantly subscription-based, supplemented by licensing and one‑time hardware and professional services revenue. The company monetizes via annual recurring subscriptions, short-term noncancelable contracts (weighted average ~1 year), and license fees, and it expands reach through regional distributors and systems integrators to penetrate government, financial and education markets. For a focused view of counterparties and go‑to‑market exposure, see Nillexposure’s relationship mapping at https://nullexposure.com/.

What this relationship map shows investors

BIO-key’s commercial model is channel-first and internationally diversified, with nearly 100% of international bookings routed through partners and roughly half of new U.S. business sold through channels such as Amazon and TD Synnex. The revenue mix includes SaaS subscriptions, perpetual licenses, hardware sales and services, creating a revenue profile that is simultaneously recurring and lumpy. The partner roster shows emphasis on financial infrastructure and public sector engagements—contracts that are operationally critical for buyers and strategically valuable for BIO-key’s ARR growth.

Key operating traits: partner-driven distribution, short contract durations, mixed product set (software + hardware + services), meaningful government and financial institution exposure.
Investment implication: growth depends on channel execution and contract renewals; margin improvement hinges on shifting revenue toward higher‑margin subscription and support streams.

If you want a compact, investor-grade extraction of these relationships, visit https://nullexposure.com/ for structured sponsor and counterparty intelligence.

Relationship roll call — each partner and customer (plain English, with sources)

Bank of Egypt

BIO-key referenced the Bank of Egypt as a recent win discussed on an earnings call, indicating a banking client engagement in the MENA region. Source: Q3 2025 earnings call transcript (mentioned Mar 7, 2026).

Sociedade Interbancária de Moçambique (SIMO) / SIMO

BIO-key signed a multi‑year strategic agreement to secure Mozambique’s national electronic payments network using PortalGuard and tokenless authentication; company press releases and multiple news outlets reported SIMO as BIO-key’s 11th financial services customer. Source: GlobeNewswire and QuiverQuant press releases (Feb–Mar 2026) and company announcements (Mar–May 2026).

Run-Level

Run‑Level is BIO-key’s implementation partner for the SIMO program, working with BIO-key to deploy identity security across Mozambique’s payments infrastructure. Source: GlobeNewswire investor release (Mar 2026).

IT2Trust

IT2Trust will distribute and support BIO-key’s full IAM and biometric portfolio across the Nordic region, indicating a channel agreement to accelerate regional adoption. Source: Yahoo Finance and GlobeNewswire announcement (Oct 2025 / Mar 2026).

Visualforma

Visualforma will lead a nationwide rollout of BIO-key’s IAM and biometric technologies across Portugal’s public sector, targeting more than 250 government organizations—this positions BIO-key for scaled public‑sector penetration via an integrator. Source: GlobeNewswire release on the Portugal contract (Jan 2026).

SAVIS Group

SAVIS Group is an authorized distributor in Vietnam, contracted to integrate and deliver BIO-key’s portfolio through local partners and enterprise customers. Source: GlobeNewswire partnership announcement (Nov 2025).

Citadel Global

Citadel Global will provide pre‑sales, deployment and customer success support for BIO‑key EMEA solutions in India, coinciding with BIO‑key opening a Mumbai presence and EMEA expansion efforts. Source: GlobeNewswire and related EMEA press (Mar 2026).

TD SYNNEX Public Sector (DLT Solutions) / TD Synnex (SNX)

BIO‑key announced a strategic partnership with TD SYNNEX Public Sector (DLT Solutions) to deliver PortalGuard and Passkey:YOU to U.S. federal, state and local agencies, opening a public‑sector sales channel for government contracts. Source: GlobeNewswire and The Globe and Mail press releases (Mar 2026).

Amazon

Amazon is named as a channel partner contributing to BIO‑key’s partner‑sold U.S. business, consistent with the company’s claim that roughly 50% of new U.S. business is sold through partners. Source: Q4 2025 earnings call transcript published on InsiderMonkey (May 2026).

Capitec Bank (CKHGF)

BIO‑key referenced Capitec Bank in South Africa as a use case where biometric solutions are deployed for both employee access and customer access, illustrating a bank client employing biometric authentication broadly. Source: Q3 2025 earnings call transcript (Mar 7, 2026). Note: an entry also appears under ticker CKHGF in the call log.

Fiber Food Systems

Fiber Food Systems is cited in BIO‑key SEC disclosures as a prospective commercial integration partner where BIO‑key’s ability to execute definitive agreements and integrate solutions is material to expected deployments. Source: GlobeNewswire SEC‑filing summary and press releases (Apr–May 2026).

VaporVM

VaporVM is listed as a regional cloud/distribution partner to expand IAM and biometric reach across the Middle East and Africa. Source: Yahoo Finance and StockTitan coverage of distribution deals (2025–2026).

Arrow ECS Iberia

Arrow ECS Iberia is identified among prior distribution partners that broaden BIO‑key’s reach in Iberia, supporting EMEA channel coverage. Source: StockTitan news roundup on EMEA partnerships (Mar 2026).

Cloud Distribution Co.

Cloud Distribution Co. is referenced as part of BIO‑key’s channel network supporting EMEA and APAC market entries. Source: StockTitan EMEA partnership coverage (Mar 2026).

Ed Tech JPA

An Ed Tech JPA partnership makes PortalGuard available to approximately 195 K‑12 institutions, indicating direct penetration into the U.S. education segment through a collective purchasing vehicle. Source: StockTitan article on Citadel Global / education partnerships (Mar 2026).

Swivel Secure

BIO‑key completed a strategic transition in EMEA away from third‑party Swivel Secure distribution to sell only BIO‑key branded solutions, a move intended to improve gross margins and rebuild the partner pipeline. Source: TradingView summary of FY2025–FY2026 activity (May 2026).

What the contractual and commercial constraints tell investors

These signals—drawn from SEC‑filed commentary and earnings call language—describe the company’s operating posture and risk profile:

Contracting posture: BIO‑key runs short‑term, noncancelable contracts with a weighted average duration of about one year, but it also sells multi‑year subscriptions and licenses; this creates recurring revenue with frequent renewal risk.
Monetization mix: The company records license fees (e.g., $2.48M noted) alongside subscription ARR and hardware, so revenue is a hybrid of one‑time and recurring streams.
Customer types and criticality: Government and financial institutions are explicit targets, signaling high criticality deployments where BIO‑key’s solutions are integrated into national payments and public‑sector systems.
Geography and concentration: Revenue is North America‑heavy but with meaningful activity across EMEA, Africa and APAC; historically the company faced receivable collection challenges in Asia/Africa and has remediated controls in EMEA.
Maturity and controls: Management disclosed a prior material weakness in revenue recording and receivables that was addressed in 2024; this is a company‑level governance signal investors must track.
Business segments: BIO‑key sells software (SaaS and perpetual), hardware (biometric devices), and services (support and professional services)—each segment has distinct margin profiles and recognition timing.

Investment takeaway

BIO-key’s channel-first, subscription‑anchored model coupled with targeted public‑sector and financial infrastructure contracts provides a credible route to ARR growth, but near‑term performance will hinge on channel execution, contract renewals and the company’s ability to convert large integrator agreements into recurring revenue. For structured counterparty intelligence and to benchmark BIO‑key’s partner exposures against peers, visit Nillexposure for the full dataset and analytic dashboard: https://nullexposure.com/.

Bold points to monitor: partner contract execution (SIMO, TD SYNNEX), renewal velocity on financial‑services licenses, and progress shifting mix to higher‑margin subscription and support revenue.

BKYI customer relationships